Novo Nordisk lowered its full-year profit forecast on Wednesday, marking an early challenge for newly appointed CEO Mike Doustdar as the Danish drugmaker grapples with slowing sales and a fast-changing obesity drug market.The maker of Wegovy, once Europe’s most valuable company, said it now expects operating profit growth in local…
European stocks opened broadly lower on Wednesday, erasing the previous session’s positive start to the month as a wave…
Yum Brands says it is exploring strategic options for Pizza Hut, a review that could include a potential sale…
Singapore has revoked the tax incentives of two single family offices linked to the US-sanctioned Prince Group, a multinational…
Asia-Pacific markets showed a mixed performance on Tuesday, with a recent rally in South Korean equities coming to a…
Global attention was fixed on a range of significant developments this past week, from a major policy speech in…
Australian households, including those without rooftop solar, are set to receive at least three hours of free solar power…
Moscow-based agricultural consultancy SovEcon has significantly increased its projection for Russian wheat exports in the 2025-26 season, raising the…
Just days after sealing a trade truce with the United States that took months of negotiations, China has issued…